Comprehensive Bioinformatics Examination of Variations Between Esophageal Adenocarcinoma and Esophageal Squamous Cell Carcinoma - Takeaways - MDSpire

Comprehensive Bioinformatics Examination of Variations Between Esophageal Adenocarcinoma and Esophageal Squamous Cell Carcinoma

  • By

  • Qi Lyu

  • Yanfei Chai

  • Wei Chen

  • Yao Chen

  • Yufei Li

  • October 29, 2025

  • 0 min

Share

  • 1

    Esophageal cancer is classified into esophageal adenocarcinoma (EAC) and esophageal squamous cell carcinoma (ESCC), differing in etiology and prognosis.

  • 2

    EAC is more prevalent in the US and Western Europe, while ESCC is common in Eastern Europe and Asia, often linked to tobacco and alcohol use.

  • 3

    EAC has a better prognosis with a 5-year survival rate of 51.9%, compared to 32.8% for ESCC, which tends to spread earlier.

  • 4

    Molecularly targeted therapies and immunotherapy show promise for treating EC, with ongoing research into specific gene mutations and biomarkers.

  • 5

    The study utilized TCGA and GEO databases to analyze gene expression and mutations, aiming to enhance treatment efficacy for EAC and ESCC.

Original Source(s)

Comprehensive Bioinformatics Examination of Variations Between Esophageal Adenocarcinoma and Esophageal Squamous Cell Carcinoma

  • by Qi Lyu, Yanfei Chai, Wei Chen, Yao Chen, Yufei Li

  • October 29, 2025

Related Content

Retraction: Enhancer RNA SLIT2 inhibits bone metastasis of breast cancer through regulating P38 MAPK/c-Fos signaling pathway

  • May 7, 2026

Pathology-based thermal ablation safety margin for follicular adenoma: a digital whole-slide study of follicular carcinoma invasion

Case Report: Synovial sarcoma with diffuse myxoid stroma and complete absence of epithelial differentiation in the extremity